MDGL vs MSFT: Which Stock is Better?
Side-by-side comparison of Madrigal Pharmaceuticals Inc and Microsoft Corporation in 2026
MDGL
Madrigal Pharmaceuticals Inc
$542.82
MSFT
Microsoft Corporation
$496.32
Key Metrics Comparison
| Metric | MDGL | MSFT | Winner |
|---|---|---|---|
| Market Cap | $11.56B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MDGL |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 362.0% | 18.4% | MDGL |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze MDGL
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MDGL or MSFT a better investment?
Comparing MDGL and MSFT: Madrigal Pharmaceuticals Inc has a market cap of $11.56B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MDGL and MSFT?
MDGL (Madrigal Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MDGL or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MDGL or MSFT?
MDGL has higher revenue growth at 362.0% vs 18.4% for MSFT.
Which company is more profitable: MDGL or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for MDGL.
Which is the larger company: MDGL or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $11.56B for MDGL.
Should I buy MDGL or MSFT in 2026?
Both MDGL and MSFT have investment merit. MDGL trades at $542.82 while MSFT trades at $496.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MDGL and MSFT stock?
Key differences: Market Cap ($11.56B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (362.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy MDGL or MSFT in 2026?
The choice between MDGL and MSFT depends on your investment goals. MDGL shows higher revenue growth (362.0%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between MDGL and MSFT?
MDGL (Madrigal Pharmaceuticals Inc) has a market cap of $11.56B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.